NCT03040427View on ClinicalTrials.gov

The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis

PHASE4TerminatedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

August 21, 2019

Study Completion Date

August 21, 2019

Conditions

Cardiac Amyloidosis

Interventions

DRUG

F-18 florbetapir

Cardiac PET images will be obtained following injection of F-18 labeled Florbetapir (Trade Name: Amyvid).

Trial Locations (1)

44195

Cleveland Clinic Foundation (Main Campus), Cleveland

Sponsors

Collaborators (1)

Avid Radiopharmaceuticals

All Listed Sponsors

collaborator

Avid Radiopharmaceuticals

INDUSTRY

lead

The Cleveland Clinic

OTHER